Free Trial

GSK (GSK) Insider Trading & Ownership

GSK logo
GBX 1,306 +6.00 (+0.46%)
(As of 05:12 AM ET)

GSK (LON:GSK) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.61%
Number Of
Insiders Buying
(Last 12 Months)
6
Amount Of
Insider Buying
(Last 12 Months)
£437,124.90
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
£2.32 M
Get GSK Insider Trade Alerts

Want to know when executives and insiders are buying or selling GSK stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GSK Insider Buying and Selling by Quarter

GSK Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2024Julie BrownInsiderBuy8GBX 1,399£111.92
10/30/2024Jonathan SymondsInsiderBuy7,150GBX 1,394£99,671
9/23/2024Elizabeth (Liz) McKee AndersonInsiderBuy446GBX 2,051£9,147.46
8/9/2024Julie BrownInsiderBuy8GBX 1,505£120.40
6/20/2024Wendy BeckerInsiderBuy446GBX 1,614£7,198.44
6/11/2024Julie BrownInsiderBuy8GBX 1,623£129.84
3/20/2024Urs RohnerInsiderBuy434GBX 1,662£7,213.08
2/16/2024Emma WalmsleyInsiderSell139,792GBX 1,658£2,317,751.36
2/9/2024Emma WalmsleyInsiderBuy8GBX 1,662£132.96
2/1/2024Julie BrownInsiderBuy19,360GBX 1,583£306,468.80
12/20/2023Urs RohnerInsiderBuy478GBX 1,450£6,931
(Data available from 1/1/2013 forward)

GSK Insider Trading Activity - Frequently Asked Questions

The list of insiders at GSK includes Charles Bancroft, Elizabeth (Liz) McKee Anderson, Emma Walmsley, Hal Barron, Iain Mackay, Jonathan Symonds, Julie Brown, Manvinder Singh Banga, Urs Rohner, and Wendy Becker. Learn more on insiders at GSK.

1.61% of GSK stock is owned by insiders. Learn more on GSK's insider holdings.

The following insiders have purchased GSK shares in the last 24 months: Elizabeth (Liz) McKee Anderson (£9,147.46), Emma Walmsley (£878.14), Hal Barron (£8,328.57), Iain Mackay (£2,986), Jonathan Symonds (£245,207), Julie Brown (£306,830.96), Urs Rohner (£25,739.02), and Wendy Becker (£7,198.44).

Insiders have purchased a total of 39,816 GSK shares in the last 24 months for a total of £606,315.59 bought.

The following insiders have sold GSK shares in the last 24 months: Emma Walmsley (£2,742,676.48), and Hal Barron (£673,220.52).

Insiders have sold a total of 187,814 GSK shares in the last 24 months for a total of £3,415,897 sold.

GSK Key Executives

  • Ms. Emma Natasha Walmsley (Age 55)
    CEO & Director
    Compensation: $5.39M
  • Ms. Julie Belita Brown (Age 62)
    CFO & Executive Director
    Compensation: $5.14M
  • Ms. Shobie Ramakrishnan (Age 53)
    Chief Digital & Technology Officer
  • Mr. Tony Wood
    Chief Scientific Officer and Head of R&D
  • Ms. Sarah Elton-Farr
    Head of Investor Relations
  • Mr. James Ford
    Senior VP & Group General Counsel of Legal & Compliance
  • Ms. Sally Jackson
    Senior Vice President of Global Communications & CEO Office
  • Mr. David Simon Redfern BSc (Hons) (Age 58)
    CA, President of Corporate Development
  • Ms. Diana Conrad
    Chief People Officer
  • Mr. Philip C. Thomson
    President of Global Affairs


This page (LON:GSK) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners